Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00798486 · ClinicalTrials.gov registry record · NA

Evaluation of the A1CNow+ Test Kit

A NA study of Diabetes, sponsored by Ascensia Diabetes Care.

Completed
Registry status
NA
Development phase
110
Enrollment target
2
Study locations

NCT00798486 is a NA study of Diabetes that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 110 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00798486, a NA study of Diabetes, has completed, sponsored by Ascensia Diabetes Care.

COMPLETED
Registry status
NA
Development phase
110 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study was to assure that consumers can successfully use the new version of A1CNow+ along with revised instructional materials.

Conditions Studied

Interventions

  • DEVICE A1C Test Kit

Study Locations (2)

California

  • John Muir Physician Network Clinical Research Center - Concord

New Jersey

  • Consumer Product Testing Co., Inc. - Fairfield

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2008-11
Est. Completion 2008-12
Phase NA

Sponsor

Ascensia Diabetes Care

42 total trials

What the Registry Record Tells You About NCT00798486

The ClinicalTrials.gov registry entry for NCT00798486 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower). The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which A1C Test Kit is the first listed.

NCT00798486 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, New Jersey.

Frequently Asked Questions

What is clinical trial NCT00798486 about?

NCT00798486 is a clinical study titled "Evaluation of the A1CNow+ Test Kit". The purpose of this study was to assure that consumers can successfully use the new version of A1CNow+ along with revised instructional materials.

What is the current status of trial NCT00798486?

This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2008-11. Estimated completion is 2008-12.

What conditions does trial NCT00798486 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT00798486?

The interventions under investigation include: A1C Test Kit (DEVICE).

Who is sponsoring clinical trial NCT00798486?

This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00798486 being conducted?

This trial has 2 study locations across California, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.